Britain opens investigation into Oasis tickets
By Steve Goldstein
Britain's competition regulator on Thursday announced an investigation into Ticketmaster sales of Oasis tickets, after fans complained about the difficulty of securing tickets to the rock band's new tour.
The Competition and Markets Authority said it's looking at Live Nation's (LYV) Ticketmaster unit, including the role dynamic pricing has played.
It said it's looking at whether the company engaged in unfair commercial practices barred under a 2008 law, if people were given clear information about dynamic pricing, and whether people were put under pressure to buy tickets with a short period of time.
The regulator said it's not illegal for a business to engage in dynamic pricing, but that companies have to inform consumers of the price they would pay as they go through the process of buying tickets, importantly before check out.
According to the BBC, fans said they were asked to pay as much as GBP350 ($461) per ticket, or about GBP200 more than initially advertised. Oasis itself said decisions on tickets and pricing were left to promoters.
Keir Starmer, Britain's new prime minister, had brought up the issue in Parliament on Wednesday. "I'm committed to putting fans at the heart of music and ending extortionate price resales, and we're starting a consultation to work out how best we can do this," Starmer said.
Live Nation stock has climbed 17% this year.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-05-24 0943ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks